20 results on '"Jin, De"'
Search Results
2. 594 EFFICACY OF HIGH-DOSE DUAL THERAPY AND BISMUTH QUADRUPLE THERAPY IN FIRST-LINE AND RESCUE HELICOBACTER PYLORI ERADICATION – A FINAL REPORT OF MULTI-CENTER, RANDOMIZED CONTROL STUDY
3. 613 ENHANCED EFFICACY OF COMBINED BISMUTH AND HIGH-DOSE DUAL THERAPY COMPARED TO HIGH-DOSE DUAL THERAPY ALONE OR QUADRUPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION – AN INTERIM REPORT OF A MULTI-CENTER, RANDOMIZED CONTROLLED STUDY
4. 594 EFFICACY OF HIGH-DOSE DUAL THERAPY AND BISMUTH QUADRUPLE THERAPY IN FIRST-LINE AND RESCUE HELICOBACTER PYLORI ERADICATION – A FINAL REPORT OF MULTI-CENTER, RANDOMIZED CONTROL STUDY
5. Su1280 – Efficacies of Tailored Therapy Versus Guideline-Recommended Empiric Therapies for Eradication of Helicobacter Pylori - a Trend Survey Over 20 Years in Taiwan (1999-2018)
6. Su1280 – Efficacies of Tailored Therapy Versus Guideline-Recommended Empiric Therapies for Eradication of Helicobacter Pylori - a Trend Survey Over 20 Years in Taiwan (1999-2018)
7. 52 - Efficacy of High-Dose Dual Therapy Versus Bismuth Quadruple Therapy for Rescue Treatment of Helicobacter Pylori — An Interim Report of Multi-Center, Randomized Control Study
8. Efficacy of High-Dose Dual Therapy Versus Bismuthcontaining Quadruple Therapy for First-Line Treatment of Helicobacter Pylori Infection and an Interim Report of Multi-Center, Randomized Control Study
9. 52 - Efficacy of High-Dose Dual Therapy Versus Bismuth Quadruple Therapy for Rescue Treatment of Helicobacter Pylori — An Interim Report of Multi-Center, Randomized Control Study
10. Efficacy of High-Dose Dual Therapy Versus Bismuthcontaining Quadruple Therapy for First-Line Treatment of Helicobacter Pylori Infection and an Interim Report of Multi-Center, Randomized Control Study
11. 316 Genotypic Testing Is Suboptimal to Predict Antibiotic Resistance and Therapeutic Outcome for Helicobacter pylori Eradication in Clinical Practice
12. 316 Genotypic Testing Is Suboptimal to Predict Antibiotic Resistance and Therapeutic Outcome for Helicobacter pylori Eradication in Clinical Practice
13. 770 High Cumulative Eradication Rate in the First-Line and Rescue Therapies for Helicobacter pylori Infection by Repeated Optimized High Dose Dual Therapy
14. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
15. 972 - Efficacy of High-Dose Dual Therapy Versus Bismuthcontaining Quadruple Therapy for First-Line Treatment of Helicobacter Pylori Infection and an Interim Report of Multi-Center, Randomized Control Study
16. 770 High Cumulative Eradication Rate in the First-Line and Rescue Therapies for Helicobacter pylori Infection by Repeated Optimized High Dose Dual Therapy
17. 564 Efficacy of Optimized High Dose Dual Therapy, Sequential Therapy and Triple Therapy in Helicobacter pylori Eradication—A Prospective, Comparative, Randomized Control Study
18. 564 Efficacy of Optimized High Dose Dual Therapy, Sequential Therapy and Triple Therapy in Helicobacter pylori Eradication—A Prospective, Comparative, Randomized Control Study
19. 378 Liver Disease Progression in Chronic Hepatitis B Infected Persons with Normal Serum Alanine Amino Transferase Level: Update from the R.E.V.E.A.L.-HBV Study
20. 378 Liver Disease Progression in Chronic Hepatitis B Infected Persons with Normal Serum Alanine Amino Transferase Level: Update from the R.E.V.E.A.L.-HBV Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.